Recent Updates
Recently added Catalysts
CHRS Positive Sentiment Score: 70/100

Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference

Wednesday, January 4, 2023 1 min read
Key Takeaway: Coherus BioSciences, Inc. will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023. The senior management presentation will be available via webcast, allowing broader accessibility. As a commercial-stage biopharmaceutical company, Coherus is focused on developing and commercializing innovative immunotherapies for cancer treatment.

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus will present at a prestigious event, highlighting its visibility in the industry.
  • The conference offers an opportunity for engagement with potential investors and stakeholders.
  • The company is focused on innovative immunotherapies, showing commitment to cutting-edge treatment development.

Full Press Release Details

REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 8:15 a.m. Pacific Time. The presentation and Q&A session will be accessible via Webcast through a link posted on the Investor Events Calendar section of the Coherus website: https://investors.coherus.com/upcoming-events. This webcast will be available for replay until February 10, 2023.
Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics.
Coherus Contact Information:
Marek Ciszewski, J.D.
SVP Investor Relations
Coherus Biosciences, Inc.

Frequently Asked Questions

When is Coherus BioSciences presenting at the J.P. Morgan Healthcare Conference?

Coherus will present on January 10, 2023, at 8:15 a.m. PT.

How can I access Coherus's conference presentation?

The presentation will be available via Webcast on Coherus's Investor Events Calendar.

Until when can I replay the Coherus webcast?

The webcast will be available for replay until February 10, 2023.

What is the focus of Coherus BioSciences?

Coherus specializes in developing immunotherapies for cancer and FDA-approved therapeutics.

Who can I contact for more information about Coherus?

For inquiries, reach out to Marek Ciszewski, SVP Investor Relations.

Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences J.P. Morgan Healthcare Conference immunotherapies biopharmaceuticals
Last updated: Jan 4, 2023